A groundbreaking CDC study shows a dramatic decline in RSV hospitalizations for infants, with new vaccines and treatments reducing rates by up to 71%. Discover how these advancements are transforming baby care and preventing severe illness.
A recent analysis reveals a dramatic decrease in RSV-associated hospitalizations among infants aged 0-7 months during the 2024-25 season, thanks to the widespread use of maternal vaccination and nirsevimab. This significant reduction highlights the effectiveness of preventive measures and underscores the importance of early intervention.
